LIANY

LianBio LIANY

LIANY
LianBio CHMMF
Chimeric Therapeutics Limited QNNTF
Quantum Genomics S.A. INTI
Inhibitor Therapeutics, Inc. OXBOF
Oxford BioDynamics Plc THER
Theralink Technologies, Inc. PHRRF
PharmaTher Holdings Ltd. CUBT
Curative Biotechnology, Inc. UNVC
Univec, Inc. BETRF
BetterLife Pharma Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode LIANY CHMMF QNNTF INTI OXBOF THER PHRRF CUBT UNVC BETRF
6M -76.83 % 0.00 % 0.00 % 4.65 % -65.00 % 0.00 % -69.07 % -27.22 % 4.00 % -39.42 %
YTD -65.38 % 0.00 % 0.00 % -30.77 % -86.00 % 0.00 % -51.25 % -44.26 % 21.50 % -45.19 %
1Y -63.45 % 0.00 % 0.00 % -31.35 % -86.00 % 0.00 % -51.76 % -45.86 % 4.00 % -45.58 %
3Y -94.17 % -98.33 % -97.06 % -54.55 % -99.29 % -96.97 % 50.00 % -57.00 % -72.34 % -66.00 %
5Y -99.31 % -98.46 % -98.20 % 18.42 % -99.88 % -99.92 % -68.42 % -73.96 % -84.62 % -96.81 %
10Y -99.31 % -98.46 % -98.20 % -63.41 % -99.88 % -100.00 % -58.31 % -49.83 % 2 500.00 % -99.59 %
From the beginning -99.31 % -98.46 % -98.20 % -99.70 % -99.88 % -100.00 % -58.31 % -100.00 % -99.97 % -99.98 %

Dividend

LianBio